Elanco Animal Health Incorporated (ELAN)
NYSE: ELAN · Real-Time Price · USD
23.33
-0.03 (-0.13%)
Mar 9, 2026, 2:54 PM EDT - Market open
Elanco Animal Health Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Revenue | 4,715 | 4,439 | 4,417 | 4,411 | 4,764 | Upgrade
|
| Revenue Growth (YoY) | 6.22% | 0.50% | 0.14% | -7.41% | 45.64% | Upgrade
|
| Cost of Revenue | 2,122 | 2,003 | 1,931 | 1,913 | 2,068 | Upgrade
|
| Gross Profit | 2,593 | 2,436 | 2,486 | 2,498 | 2,696 | Upgrade
|
| Selling, General & Admin | 1,423 | 1,308 | 1,280 | 1,259 | 1,395 | Upgrade
|
| Research & Development | 368 | 344 | 327 | 321 | 369 | Upgrade
|
| Amortization of Goodwill & Intangibles | 543 | 527 | 548 | 528 | 556 | Upgrade
|
| Operating Expenses | 2,334 | 2,179 | 2,155 | 2,108 | 2,320 | Upgrade
|
| Operating Income | 259 | 257 | 331 | 390 | 376 | Upgrade
|
| Interest Expense | -245 | -266 | -286 | -241 | -236 | Upgrade
|
| Interest & Investment Income | 45 | 31 | 9 | - | - | Upgrade
|
| Currency Exchange Gain (Loss) | -14 | -12 | -40 | -28 | -35 | Upgrade
|
| Other Non Operating Income (Expenses) | -12 | -4 | -40 | -10 | 22 | Upgrade
|
| EBT Excluding Unusual Items | 33 | 6 | -26 | 111 | 127 | Upgrade
|
| Merger & Restructuring Charges | -158 | -62 | -93 | -98 | -336 | Upgrade
|
| Impairment of Goodwill | - | - | -1,042 | - | - | Upgrade
|
| Gain (Loss) on Sale of Investments | - | -8 | - | - | - | Upgrade
|
| Gain (Loss) on Sale of Assets | - | 640 | - | - | - | Upgrade
|
| Asset Writedown | -71 | -81 | -32 | -81 | - | Upgrade
|
| Legal Settlements | - | - | - | - | -10 | Upgrade
|
| Other Unusual Items | -28 | -7 | -2 | -4 | -352 | Upgrade
|
| Pretax Income | -224 | 488 | -1,195 | -72 | -571 | Upgrade
|
| Income Tax Expense | 8 | 150 | 36 | 6 | -88 | Upgrade
|
| Net Income | -232 | 338 | -1,231 | -78 | -483 | Upgrade
|
| Net Income to Common | -232 | 338 | -1,231 | -78 | -483 | Upgrade
|
| Shares Outstanding (Basic) | 496 | 494 | 492 | 488 | 487 | Upgrade
|
| Shares Outstanding (Diluted) | 496 | 497 | 492 | 488 | 487 | Upgrade
|
| Shares Change (YoY) | -0.18% | 1.02% | 0.82% | 0.23% | 10.38% | Upgrade
|
| EPS (Basic) | -0.47 | 0.68 | -2.50 | -0.16 | -0.99 | Upgrade
|
| EPS (Diluted) | -0.47 | 0.68 | -2.50 | -0.16 | -0.99 | Upgrade
|
| Free Cash Flow | 284 | 394 | 131 | 281 | 324 | Upgrade
|
| Free Cash Flow Per Share | 0.57 | 0.79 | 0.27 | 0.57 | 0.67 | Upgrade
|
| Gross Margin | 55.00% | 54.88% | 56.28% | 56.63% | 56.59% | Upgrade
|
| Operating Margin | 5.49% | 5.79% | 7.49% | 8.84% | 7.89% | Upgrade
|
| Profit Margin | -4.92% | 7.61% | -27.87% | -1.77% | -10.14% | Upgrade
|
| Free Cash Flow Margin | 6.02% | 8.88% | 2.97% | 6.37% | 6.80% | Upgrade
|
| EBITDA | 908 | 879 | 971 | 1,007 | 1,040 | Upgrade
|
| EBITDA Margin | 19.26% | 19.80% | 21.98% | 22.83% | 21.83% | Upgrade
|
| D&A For EBITDA | 649 | 622 | 640 | 617 | 664 | Upgrade
|
| EBIT | 259 | 257 | 331 | 390 | 376 | Upgrade
|
| EBIT Margin | 5.49% | 5.79% | 7.49% | 8.84% | 7.89% | Upgrade
|
| Effective Tax Rate | - | 30.74% | - | - | - | Upgrade
|
| Advertising Expenses | 314 | 236 | 207 | 201 | 248 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.